The 8 analysts offering 12-month price forecasts for Core Laboratories NV have a median target of 20.50, with a high estimate of 32.00 and a low estimate of 17.00. The median estimate represents a +19.53% increase from the last price of 17.15.
The current consensus among 9 polled investment analysts is to Hold stock in Core Laboratories NV. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.15
Reporting Date Oct 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.